44.56
-0.52(-1.15%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
777
First IPO Date
December 28, 2021
| Name | Title | Pay | Year Born |
| Mr. Ruilin Sun | Deputy General Manager | 0 | 1980 |
| Ms. Wen Liu | Secretary of the Board of Directors | 0 | 1990 |
| Pinglan Wang | Accounting Supervisor | 0 | N/A |
| Mr. Mingjun Wang | GM & Director | 0 | 1972 |
| Mr. Rongxin Zhou | Deputy GM & Financial Director | 0 | 1974 |
| Mr. Dongxiao Feng | Deputy General Manager | 0 | 1970 |
Shanghai Model Organisms Center, Inc. engages in the research and development of genetically modified animal models in China. It develops tool, disease, fluorescent reporter, humanized, and immunodeficient mice; humanized, immunodeficient, disease, tool, and fluorescent reporter rats; and fluorescent-labeled, primary, and humanized cells. It also provides model customization, living body model, breeding, phenotypic analysis, and drug screening and evaluation services. The company was founded in 2000 and is headquartered in Shanghai, China.